DRUG NAME MODE OF ACTION INDICATION CONTRAINDICATION SIDE/ADVERSE NURSING

EFFECTS RESPONSIBILITIES
Drug Name: Competitively blocks  Tourette disorders  Seizure disorder  Extrapyramidal  Monitor for
- Haldol, Peridol dopamine receptors to  Severe behavioral  Glaucoma symptoms such as therapeutic
cause sedation and problems  Elderly clients muscle rigidity or effectiveness
Generic Name: also causes alpha-  Short term spasm  Monitor patients
-Haloperidol Decanoate adrenergic and treatment of  Posture leaning mental status daily
anticholinergic hyperactive forward  Monitor for
Classification: blockade. It depresses children  Masklike facial neuroleptic
-Antipsychotic cerebral cortex and  Long term appearance malignant syndrome
hypothalamus and antipsychotic  Blurred vision  Monitor Vital signs
Dosage: limbic system, which therapy  Urinary frequency frequently
- 10 mg OD control activity and  Autism  Anemia  Observe patient
- 5 mg/mL IV aggression byt also  carefully when
Chorea  Photosensitivity
cause significant administering
 Alcohol  Dry mouth
Route: extrapyramidal effects. medication
dependence  Nausea-vomiting
-PO,IV The mechanisms for  Monitor I&O ratios
 Seizures  Anorexia
antipsychotic effects daily
Frequency: are unclear.
- OD
DRUG NAME MODE OF ACTION INDICATION CONTRAINDICATION SIDE/ADVERSE NURSING
EFFECTS RESPONSIBILITIES
Drug Name: Inhibits  Mania  Older adults  Restlessness  Monitor response to
- Eskalith neurotransmitters;  Bipolar disorder  Thyroid disease  Loss of appetite drug
decreases over-activity  Abnormal  Epilepsy  Weight gain or  Monitor lithium level
Generic Name: of receptors involved in excitement  Concomitant use weight loss  Monitor for signs
-Lithium Carbonate stimulating manic  Depression with haloperidol  Stomach pain, gas, and symptoms of
states. Response  Schizophrenia  Parkinsonism constipation or lithium toxicity
Classification: evidenced by changed  Eating disorders  Diabetes mellitus indigestion
-CNS agent facial affect, improved  Mild thirst
 Impulse control  Severe infections
-Psychotherapeutic posture, assumption of  Dry mouth
disorders  Urinary retention
agent self-care, improved
 Alcoholism  Excessive saliva in
-Anti-manic ability to concentrate,
mouth
improved sleep
 Change in the
Dosage: pattern.
ability to taste food
- 45 mg 1 tab
 Swollen lips
 Acne
Route:
-PO  Hair loss
 Extreme discomfort
Frequency: in cold temperature
- OD  Depression
 Muscle or joint pain
 Itching or rash
DRUG NAME MODE OF ACTION INDICATION CONTRAINDICATION SIDE/ADVERSE NURSING
EFFECTS RESPONSIBILITIES
Drug Name: Depress the CNS,  Status epilepticus  Hypersensitivity to  Dizziness  Monitor vital signs
- Valium probably by  Anxiety disorder drug  Drowsiness periodically
potentiating GABA,  Amnesic  Cross-sensitivity  Lethargy throughout the
Generic Name: and inhibitory  Treatment for with other  Headache therapy and
-Diazepam neurotransmitter. Has restless legs benzodiazepines  Depression frequency during IV
therapeutic effects to  Acute withdrawal  Comatose patients therapy
 Blurred vision
Classification: relief of anxiety, symptoms of  Pre-existing CNS  Monitor signs and
 Respiratory
-Antianxiety agents sedation, amnesia, alcoholism depression symptoms
depression
-Anticonvulsants skeletal muscle  Voiding problems  Uncontrolled  Observe and record
 Hypotension
-Sedative relaxant, decreased severe pain intensity, duration
 Skeletal muscle  Constipation
seizure activity  Hepatic dysfunction and location of
spasm  Diarrhea
Dosage: seizure activity
 Cerebral palsy  Severe renal  Nausea
- 2,5,10 mg 1 tab  Instruct patient to
 Paraplegia impairment  Vomiting
-5 mg/mL avoid alcohol during
 Athetosis  History of suicide  Rashes
attempt treatment
Route:  Stiff-man  Pain
 Drug dependence  Monitor for
-PO syndrome  Phlebitis therapeutic
-IV effectiveness
 Check for lab test
Frequency: result before
- Tablet – BID administration of
-IV – q3-q4 PRN drug